Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z7AB
|
|||
Former ID |
DNCL002812
|
|||
Drug Name |
Olodaterol/tiotropium bromide
|
|||
Synonyms |
136310-93-5; UNII-XX112XZP0J; XX112XZP0J; (1R,2R,4S,5S,7s)-7-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide; AK-72842; (1R,2R,4S,5S,7S)-7-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Phase 3 | [1] | |
Company |
Boehringer Ingelheim Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H22BrNO4S2
|
|||
Canonical SMILES |
C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]
|
|||
InChI |
1S/C19H22NO4S2.BrH/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15;/h3-8,11-13,16-17,22H,9-10H2,1-2H3;1H/q+1;/p-1/t11?,12-,13+,16-,17+;
|
|||
InChIKey |
DQHNAVOVODVIMG-RGECMCKFSA-M
|
|||
CAS Number |
CAS 136310-93-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
12014767, 16431254, 16516650, 37101841, 57364284, 78006594, 92309156, 92714242, 93302582, 121264529, 125003137, 126592377, 126624303, 126655544, 134224129, 134337655, 135087660, 135693784, 136376471, 136946674, 144206151, 152059683, 152258759, 152343784, 160647604, 162038024, 162170559, 164194996, 164814954, 172440019, 172440020, 172919722, 174476476, 175268305, 180673829, 184811782, 187072489, 196106129, 198991441, 223658400, 226399777, 226763578, 233206887, 241032671, 242592071, 249845981, 250203609, 251916428, 251917775, 252039050
|
|||
ChEBI ID |
CHEBI:90959
|
References | Top | |||
---|---|---|---|---|
REF 1 | Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease. Expert Rev Clin Pharmacol. 2015 Aug 13:1-11. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.